Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1I | Q9P0X4 | 5/20 | 0.73 |
| ▸ | CACNA1H | O95180 | 4/20 | 0.73 |
| ▸ | CACNA1G | O43497 | 3/20 | 0.73 |
| ▸ | CNR2 | P34972 | 2/20 | 0.73 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.73 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1063626 | 0.90 | CACNA1I (0.72) | CACNA1ICACNA1HCACNA1GCNR2KCNH2 | |
| SCHEMBL17451435 | 0.89 | CACNA1I (0.59) | CACNA1ICACNA1HCACNA1GCNR2KCNH2 | |
| SCHEMBL1063192 | 0.87 | CACNA1I (0.78) | CACNA1ICACNA1HCACNA1GCNR2KCNH2 | |
| SCHEMBL1062854 | 0.87 | CACNA1I (0.75) | CACNA1ICACNA1HCACNA1GCNR2KCNH2 | |
| SCHEMBL8234415 | 0.87 | CACNA1I (0.68) | CACNA1ICACNA1HCACNA1GCNR2KCNH2 | |
| SCHEMBL1061452 | 0.86 | CACNA1I (0.73) | CACNA1ICACNA1HCACNA1GCNR2KCNH2 | |
| Suvecaltamide SCHEMBL1065999 | 0.84 | CACNA1I (1.00) | CACNA1ICACNA1HCACNA1GCNR2KCNH2 | |
| Suvecaltamide SCHEMBL29791943 | 0.84 | CACNA1I (1.00) | CACNA1ICACNA1HCACNA1GCNR2KCNH2 | |
| Suvecaltamide SCHEMBL21828396 | 0.84 | CACNA1I (1.00) | CACNA1ICACNA1HCACNA1GCNR2KCNH2 | |
| SCHEMBL1063221 | 0.84 | CACNA1I (0.73) | CACNA1ICACNA1HCACNA1GCNR2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2010493-B1 | PYRIDYL AMIDE T-TYPE CALCIUM CHANNEL ANTAGONISTS | MERCK SHARP & DOHME (US) | 2016-01-27 | — | — | EP | claimed |
| US-20090275550-A1 | Pyridyl Amide T-Type Calcium Channel Antagonists | MERCK SHARP & DOHME LLC | 2009-11-05 | — | — | US | claimed |
| US-20090275550-A1 | Pyridyl Amide T-Type Calcium Channel Antagonists | MERCK SHARP & DOHME LLC | 2009-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090275550-A1 | Pyridyl Amide T-Type Calcium Channel Antagonists | CACNA1G, CACNA1H, CACNA1I | CACNA1I 3/4885CACNA1H 2/4885CACNA1G 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.